1 |
Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K. Current Protocols in Molecular Biology. Wiley, New York, 1996
|
2 |
Bosse JT, Janson H, Sheehan BJ, Beddek AJ, Rycroft AN, Kroll JS, Landford PR. A. pleuropneumoniae: pathobiology and pathogenesis of infection. Microbes Infect 2002, 4, 225-235
DOI
ScienceOn
|
3 |
Chiers K, van Overbeke I, de Laender P, Ducatelle R, Carel S, Haesebrouck F. Effects of endothelial challenge with Actinobacillus pleuropneumoniae serotype 9 of pigs vaccinated with inactivated vaccines containing the Apx toxins. Vet Q 1998, 20, 65-69
DOI
ScienceOn
|
4 |
Kamp EM, Stockhofe-Zurwieden N, van Leengoed LAMG, Smits MA. Endobronchial inoculation with Apx toxins of Actinobacillus pleuropneumoniae leads to pleuropneumonia in pigs. Infect Immun 1997, 65, 4350-4354
|
5 |
Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1989
|
6 |
신성재, 조영욱, 유한상. 국내분리 흉막폐렴균의 apxIA, IIA, IIA 유전자 cloning, 염기서열 분석 및 단백질 발현. 대한수의학회지 2003, 43, 247-253
|
7 |
Prideaux CT, Lenghaus C, Krywult J, Hodgson ALM. Vaccination and protection of pigs against pleuropneumonia with a vaccine strain of Actinobacillus pleuropneumoniae produced by site-specific mutagenesis of the Apx II operon. Infect Immun 1999, 67, 1962-1966
|
8 |
Jarma E, Corradino G, Regassa LB. Anaerobiosis, growth phase and Actinobacillus pleuropneumoniae RTX toxin production. Microb Pathog 2004, 37, 29-33
DOI
ScienceOn
|
9 |
Frey J. Virulence in Actinobacillus pleuropneumoniae and RTX toxins. Trends Microbiol 1995, 3, 257-261
DOI
PUBMED
ScienceOn
|
10 |
Van den Bosch H, Frey J. Interference of outer membrane protein PalA with protective immunity against Actinobacillus pleuropneumoniae infections in vaccinated pigs. Vaccine 2003, 21, 3601-3607
DOI
ScienceOn
|
11 |
Haesebrouck F, Pasmans F, Chiers K, Maes D, Ducatelle R, Decostere A. Efficacy of vaccines against bacterial diseases in swine: what can we expect? Vet Microbiol 2004, 100, 255-268
DOI
PUBMED
ScienceOn
|
12 |
Chiers K, Donne E, van Overbeke I, Ducatelle R, Haesebrouck F. Actinobacillus pleuropneumoniae infections in closed swine herds: infection patterns and serological profiles. Vet Microbiol 2002, 85, 343-352
DOI
ScienceOn
|
13 |
Burdychova R, Rychtera M, Horvath R, Dendis M, Bartos M. Expression of Actinobacillus pleuropneumoniae gene coding for Apx I protein in Escherichia coli. FEMS Microbiol Lett 2004, 230, 9-12
DOI
ScienceOn
|
14 |
Van Overbeke I, Chiers K, Donne E, Ducatelle R, Haesebrouck F. Effects of endothelial challenge with Actinobacillus pleuropneumoniae serotype 9 of pigs vaccinated with a vaccine containing Apx toxins and tranferrin-binding proteins. J Vet Med B 2001, 48, 15-20
DOI
ScienceOn
|
15 |
Seah JN, Frey J, Kwang J. The N-terminal domain of RTX toxin Apx I of Actinobacillus pleuropneumoniae elicits protective immunity in mice. Infect Immun 2002, 70, 6464-6467
DOI
ScienceOn
|
16 |
Haesebrouck F, Chiers K, van Overbeke I, Ducatelle R. A. pleuropneumoniae infections in pigs: the role of virulence factors in pathogenesis and protection. Vet Microbiol 1997, 58, 239-249
DOI
ScienceOn
|